Patent · US Active

Compositions and methods for the modulation of JNK proteins

US8101585B2 · kind B2 · utility

19Cited by
46References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 2007
Grant dateJan 24, 2012
Priority date
Expiry dateAug 6, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/346
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a gene encoding a Jun N-terminal kinase 1 (JNK1 protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.